Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Compared to R2 in Subjects with Relapsed or Refractory Follicular Lymphom
Sponsored by AbbVie Incorporated
Active
$1.2M Funding
1 People
External
Related Topics
lymphoma,
efficacy,
safety,
treatment,
clinical trial
People
Bital Savir-Baruch
Co-Investigator (COI)
Medical Imaging
﹒Professor
